WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
CCTF Holds Training Session for Guizhou's Middle School English Teachers at BFSU70th Anniversary of Founding of Gannan Tibetan Autonomous Prefecture Celebrated in GansuTen 'Comfort Women' Still Living on Chinese MainlandChina Launches New Disaster Reduction Satellite70th Anniversary of Founding of Gannan Tibetan Autonomous Prefecture Celebrated in GansuChangshan Shows the Way to Boost BirthsTen 'Comfort Women' Still Living on Chinese MainlandWorld Robot Conference 2023 Opens in BeijingDay 4 Roundup: China Continues Dominance with 23 Golds, Another Shooting World Record ShatteredSmart China Expo 2023 Opens in China's Chongqing
2.9687s , 6499.65625 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Gazette news portal